Pharmaceuticals; pharmaceuticals for use in treating paraneoplastic and neoplastic diseases and cancer; pharmaceuticals for use as prophylaxis or treatment of infectious diseases; pharmaceuticals for use as adjuvant to vaccination; pharmaceuticals for use in expanding cell populations in ex vivo settings or processes; pharmaceuticals for use in the treament of immune diseases and immune deficiencies.
WITHDRAWN BY OWNER
on 14 Mar 2002
AVREND
IMMUNEX CORPORATION
A WASHINGTON CORPORATION
1045649 · 08 Feb 2000
005
Class 005
Pharmaceutical Products
Pharmaceuticals; pharmaceuticals for use in treating paraneoplastic and neoplastic diseases and cancer; pharmaceuticals for use as prophylaxis or treatment of infectious diseases; pharmaceuticals for use as adjuvant to vaccination; pharmaceuticals for use in expanding cell populations in ex vivo settings or processes; pharmaceuticals for use in the treament of immune diseases and immune deficiencies.
Pharmaceuticals; pharmaceuticals for use in treating paraneoplastic an...
